Imaging agent developer ImaginAb has appointed Joseph Limber as chairman of the board and Benjamin Chen, PhD, as its new CEO.
Limber spent nearly a decade with Prometheus Laboratories as president, CEO, and director, overseeing all business operations and commercial strategies of the company's diagnostics and pharmaceutical products for personalized clinical management.
Chen previously served as chairman and CEO of Immune Targeting Systems, where he helped lead the immune therapy company's strategic growth and product development.
ImaginAb has also created a medical advisory board to advance the development of products through ImaginAb's antibody-based imaging technology.
